MUMBAI / LONDON: The Serum Institute of India has suspended trials of AstraZeneca’s Covid-19 vaccine candidate until the British drugmaker restarts trials, Serum said on Thursday. “We are reviewing the situation and stopping the trials in India,” Serum said in a short statement. AstraZeneca said Tuesday that it had halted …
Read More »
NEW DELHI: India’s central drug regulator issued a notice to the Pune-based Serum Institute of India (SII) on Wednesday, asking why the company had failed to inform it of the “reported serious adverse events” that led to UK partner AstraZeneca to “temporarily pause” global clinical trials of the Oxford Covid …
Read More »
LONDON: AstraZeneca has halted global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, which has taken a toll on the British drugmaker’s actions, as the move was seen to reduce the prospects of a launch early. “This is a routine action that has to happen …
Read More »
Meanwhile, a multi-center study funded by the Indian Council for Medical Research (ICMR) has found that the use of convalescent plasma therapy in coronavirus-infected patients does not help reduce mortality or progression to severe Covid-19. The ‘open parallel arm phase II multicenter randomized controlled trial’ (PLACID trial) was conducted in …
Read More »
Written by Amitabh Sinha | Pune | September 9, 2020 9:47:23 am A sign with the AstraZeneca Plc logo stands on the company’s DaVinci building at Melbourn Science Park in Cambridge, UK (Photographer: Jason Alden / Bloomberg) Phase 3 clinical trials of a coronavirus vaccine being developed by AstraZeneca, in …
Read More »
Meanwhile, a multi-center study funded by the Indian Council for Medical Research (ICMR) has found that the use of convalescent plasma therapy in coronavirus-infected patients does not help reduce mortality or progression to severe Covid-19. The ‘open parallel arm phase II multicenter randomized controlled trial’ (PLACID trial) was conducted in …
Read More »
AstraZeneca Plc has halted a late-stage trial of one of the leading Covid-19 vaccine candidates after a suspected serious adverse reaction in a study participant, health news website Stat News reported Tuesday. He quoted an AstraZeneca spokesperson as saying in a statement that the “standard review process caused a pause …
Read More »
NEW DELHI: Clinical trials for the Covid-19 candidate vaccine developed by the University of Oxford, which were expected to begin at the Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh, have been delayed for at least a week. Trials that were expected to begin in the first week …
Read More »
A volunteer receives the Covid-19 vaccine from Yaquelin De La Cruz at the Research Centers of America in Hollywood, Florida on August 13, 2020 (Photo by CHANDAN KHANNA / AFP). To establish the degree of certainty of the vaccine’s effectiveness in the real world, an experiment requires tens of thousands …
Read More »
The first results showing whether a vaccine can prevent people from contracting the virus could come in mid-September from AstraZeneca Plc, according to Airfinity Ltd., an analytics company that tracks drug trials. The drug maker has promised up to 30 million doses for the UK by the end of the …
Read More »